| 1 |
23157194 | The metabolic rationale for a lack of cross-reactivity between sulfonamide antimicrobials and other sulfonamide-containing drugs. | 2012 Jun 1 |
1 |
| 2 |
18765684 | Nonenzymatic formation of a novel hydroxylated sulfamethoxazole derivative in human liver microsomes: implications for bioanalysis of sulfamethoxazole metabolites. | 2008 Dec |
1 |
| 3 |
15843491 | Identification of cytochrome P450 and arylamine N-acetyltransferase isoforms involved in sulfadiazine metabolism. | 2005 Jul |
3 |
| 4 |
14718257 | 5-Hydroxytryptamine is biotransformed by CYP2C9, 2C19 and 2B6 to hydroxylamine, which is converted into nitric oxide. | 2004 Feb |
1 |
| 5 |
11408370 | Dapsone activation of CYP2C9-mediated metabolism: evidence for activation of multiple substrates and a two-site model. | 2001 Jul |
1 |
| 6 |
10208642 | The effect of genetic polymorphisms in CYP2C9 on sulphamethoxazole N-hydroxylation. | 1999 Feb |
1 |
| 7 |
9131488 | N-acetyltransferases: pharmacogenetics and clinical consequences of polymorphic drug metabolism. | 1996 Oct |
1 |